Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology
Key claim: Dendritic-cell antigen presentation enables peripheral T cells to enter the brain and contribute to tau pathology, alongside age-related blood-brain barrier leakiness and microglial inflammation.
Abstract
The immune systems of the body and brain are distinct and separate, or at least largely separate, influencing one another via signaling. The blood-brain barrier keeps the vast majority of immune cells in the body out of the brain, and vice versa. A few channels have been discovered in recent years whereby a small number of adaptive immune cells, such as T cells, enter the brain in the normal course of events. Additionally, the blood-brain barrier becomes dysfunctional and leaky with age, allowing a wide range of unwanted cells into the brain, T cells included. Increasing inflammatory activity in the innate immune cells of the brain known as microglia is a growing focus of research interest in the context of aging and neurodegenerative conditions. While […]
Why this matters
Most aging-neurodegeneration mechanism work in this vault has centered on microglia, complement, and BBB integrity; a dendritic-cell → T-cell axis inserts adaptive immunity as a discrete route into tau pathology and reframes some of what has been attributed to generic ‘neuroinflammation’ as peripherally licensed cellular trafficking. The claim currently rests on news-reported preclinical work, so its weight is mechanism-plausible and it does not upgrade the human-translation status of any downstream anti-tau or immune-modulation pitch.